ZA975631B - Matrix metalloproteinase inhibitors. - Google Patents
Matrix metalloproteinase inhibitors.Info
- Publication number
- ZA975631B ZA975631B ZA9705631A ZA975631A ZA975631B ZA 975631 B ZA975631 B ZA 975631B ZA 9705631 A ZA9705631 A ZA 9705631A ZA 975631 A ZA975631 A ZA 975631A ZA 975631 B ZA975631 B ZA 975631B
- Authority
- ZA
- South Africa
- Prior art keywords
- matrix metalloproteinase
- metalloproteinase inhibitors
- inhibitors
- matrix
- metalloproteinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9613547.0A GB9613547D0 (en) | 1996-06-27 | 1996-06-27 | Matrix metalloproteinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA975631B true ZA975631B (en) | 1998-01-30 |
Family
ID=10796022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9705631A ZA975631B (en) | 1996-06-27 | 1997-06-25 | Matrix metalloproteinase inhibitors. |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0920414A1 (en) |
JP (1) | JP2000514043A (en) |
KR (1) | KR20000022534A (en) |
AR (1) | AR008621A1 (en) |
AU (1) | AU733938B2 (en) |
BR (1) | BR9709902A (en) |
CA (1) | CA2257404A1 (en) |
CZ (1) | CZ430398A3 (en) |
EA (1) | EA001432B1 (en) |
GB (1) | GB9613547D0 (en) |
ID (1) | ID17792A (en) |
IL (1) | IL127262A0 (en) |
NO (1) | NO986049L (en) |
NZ (1) | NZ333550A (en) |
PL (1) | PL330897A1 (en) |
TW (1) | TW460441B (en) |
WO (1) | WO1997049674A1 (en) |
ZA (1) | ZA975631B (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19719817A1 (en) * | 1997-05-13 | 1998-11-19 | Hoechst Ag | Substituted 6- and 7-aminotetrahydroisoquinoline carboxylic acids |
NZ503945A (en) | 1997-07-31 | 2002-11-26 | Procter & Gamble | Metalloprotease-inhibiting amide derivatives |
GB9803005D0 (en) * | 1998-02-12 | 1998-04-08 | British Biotech Pharm | Anti-inflammatory agents |
GB9804777D0 (en) * | 1998-03-07 | 1998-04-29 | British Biotech Pharm | Anti-inflammatory agents |
US6335324B1 (en) | 1998-06-25 | 2002-01-01 | Bristol-Myers Squibb Co. | Beta lactam compounds and their use as inhibitors of tryptase |
GB9901863D0 (en) | 1999-01-29 | 1999-03-17 | British Biotech Pharm | Antibacterial agents |
NZ513831A (en) | 1999-03-03 | 2001-09-28 | Procter & Gamble | Alkenyl- and alkynyl-containing metalloprotease inhibitors |
WO2001044179A1 (en) * | 1999-12-17 | 2001-06-21 | Versicor, Inc. | Novel succinate compounds, compositions and methods of use and preparation |
GB9930754D0 (en) * | 1999-12-29 | 2000-02-16 | Smithkline Beecham Plc | Novel compounds |
AU2001271068A1 (en) * | 2000-07-18 | 2002-01-30 | Chugai Seiyaku Kabushiki Kaisha | Matrix metalloprotease inhibitors |
AR036053A1 (en) | 2001-06-15 | 2004-08-04 | Versicor Inc | N-FORMIL-HYDROXYLAMINE COMPOUNDS, A PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS |
DK1406893T3 (en) | 2001-06-15 | 2007-08-06 | Vicuron Pharm Inc | Bicyclic pyrrolidine compounds |
US20110230479A1 (en) * | 2005-04-15 | 2011-09-22 | Longo Frank M | Neurotrophin mimetics and uses thereof |
KR20060116552A (en) * | 2005-05-10 | 2006-11-15 | 연세대학교 산학협력단 | N-formyl hydroxylamine derivatives as matrix metalloproteinase inhibitors |
FR2949463B1 (en) * | 2009-08-26 | 2011-09-16 | Commissariat Energie Atomique | MMP INHIBITORS |
US9271986B2 (en) | 2009-11-12 | 2016-03-01 | Pharmatrophix, Inc. | Crystalline forms of neurotrophin mimetic compounds and their salts |
US10273219B2 (en) | 2009-11-12 | 2019-04-30 | Pharmatrophix, Inc. | Crystalline forms of neurotrophin mimetic compounds and their salts |
US20210393632A1 (en) | 2018-10-04 | 2021-12-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Egfr inhibitors for treating keratodermas |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4599361A (en) * | 1985-09-10 | 1986-07-08 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
DK77487A (en) * | 1986-03-11 | 1987-09-12 | Hoffmann La Roche | hydroxylamine |
JPH05503720A (en) * | 1990-12-03 | 1993-06-17 | セルテック リミテッド | Peptidyl derivative |
CA2058797A1 (en) * | 1991-02-01 | 1992-08-02 | Michael John Broadhurst | Amino acid derivatives |
EP0520573A1 (en) * | 1991-06-27 | 1992-12-30 | Glaxo Inc. | Cyclic imide derivatives |
-
1996
- 1996-06-27 GB GBGB9613547.0A patent/GB9613547D0/en active Pending
-
1997
- 1997-06-18 TW TW086108613A patent/TW460441B/en active
- 1997-06-20 IL IL12726297A patent/IL127262A0/en unknown
- 1997-06-20 JP JP10502322A patent/JP2000514043A/en active Pending
- 1997-06-20 WO PCT/EP1997/003251 patent/WO1997049674A1/en not_active Application Discontinuation
- 1997-06-20 BR BR9709902A patent/BR9709902A/en unknown
- 1997-06-20 KR KR1019980710980A patent/KR20000022534A/en not_active Application Discontinuation
- 1997-06-20 EP EP97929242A patent/EP0920414A1/en not_active Withdrawn
- 1997-06-20 EA EA199900057A patent/EA001432B1/en not_active IP Right Cessation
- 1997-06-20 CZ CZ984303A patent/CZ430398A3/en unknown
- 1997-06-20 NZ NZ333550A patent/NZ333550A/en unknown
- 1997-06-20 AU AU33422/97A patent/AU733938B2/en not_active Ceased
- 1997-06-20 PL PL97330897A patent/PL330897A1/en unknown
- 1997-06-20 CA CA002257404A patent/CA2257404A1/en not_active Abandoned
- 1997-06-25 ZA ZA9705631A patent/ZA975631B/en unknown
- 1997-06-26 ID IDP972218A patent/ID17792A/en unknown
- 1997-06-26 AR ARP970102813A patent/AR008621A1/en unknown
-
1998
- 1998-12-22 NO NO986049A patent/NO986049L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU3342297A (en) | 1998-01-14 |
CZ430398A3 (en) | 1999-08-11 |
KR20000022534A (en) | 2000-04-25 |
AR008621A1 (en) | 2000-02-09 |
JP2000514043A (en) | 2000-10-24 |
NO986049L (en) | 1999-03-01 |
EA199900057A1 (en) | 1999-06-24 |
BR9709902A (en) | 1999-08-10 |
EA001432B1 (en) | 2001-02-26 |
EP0920414A1 (en) | 1999-06-09 |
NO986049D0 (en) | 1998-12-22 |
TW460441B (en) | 2001-10-21 |
GB9613547D0 (en) | 1996-08-28 |
PL330897A1 (en) | 1999-06-07 |
ID17792A (en) | 1998-01-29 |
WO1997049674A1 (en) | 1997-12-31 |
IL127262A0 (en) | 1999-09-22 |
AU733938B2 (en) | 2001-05-31 |
CA2257404A1 (en) | 1997-12-31 |
NZ333550A (en) | 2000-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA977695B (en) | 1,4-heterocyclic metalloprotease inhibitors. | |
TR199501472A2 (en) | Matrix metalloprotease inhibitors. | |
ZA977693B (en) | 1,3-diheterocyclic metalloprotease inhibitors. | |
ZA977969B (en) | Reflux inhibitors. | |
ZA977696B (en) | Diheterocyclic metalloprotease inhibitors. | |
ZA988967B (en) | Lactam metalloprotease inhibitors. | |
PL328307A1 (en) | Serinic protease inhibitors | |
ZA975631B (en) | Matrix metalloproteinase inhibitors. | |
ZA9811794B (en) | Ace inhibitor-MMP inhibitor combinations. | |
AU8858398A (en) | Matrix metalloproteinase inhibitors | |
ZA96850B (en) | Matrix metalloprotease inhibitors. | |
IL128665A0 (en) | Bidenatate metalloprotease inhibitors | |
PL328223A1 (en) | Aspartil protease inhibitors | |
ZA978307B (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase. | |
IL136889A0 (en) | Matrix metalloprotease inhibitors | |
GB9624817D0 (en) | Metalloproteinase inhibitors | |
ZA974779B (en) | Thrombin inhibitors. | |
GB9707333D0 (en) | Metalloproteinase inhibitors | |
ZA977209B (en) | Thrombin inhibitors. | |
AU9747098A (en) | Aporphinoid matrix metalloproteinase inhibitors | |
ZA992106B (en) | Statin-MMP inhibitor combinations. | |
IL132843A0 (en) | Metalloproteinase inhibitors | |
GB9702085D0 (en) | Matrix metalloproteinase inhibitors | |
SI0901466T1 (en) | Biphenylsulfonamide matrix metalloproteinase inhibitors | |
ZA9710611B (en) | Metalloproteinase inhibitors. |